140 results on '"Fosgerau, Keld"'
Search Results
2. Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
3. Rodent models of diabetic kidney disease: human translatability and preclinical validity
4. Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development
5. Mouse models of nonalcoholic steatohepatitis in preclinical drug development
6. Peptide therapeutics: current status and future directions
7. In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes
8. The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats
9. An Aldehyde Responsive, Cleavable Linker for Glucose Responsive Insulins
10. Rodent models of diabetic kidney disease:human translatability and preclinical validity
11. Compartmentation of Lactate Originating from Glycogen and Glucose in Cultured Astrocytes
12. An Aldehyde Responsive, Cleavable Linker for Glucose Responsive Insulins
13. 457-P: Quantification of Vascular Density by 3D Light Sheet Imaging in a Surgical Ligation of the Left Anterior Descending Artery (LAD) Model in Mouse
14. 483-P: Key Biochemical and Histopathological Markers of Diabetic Nephropathy Correlate with Hypertension in the Renin-AAV Uninephrectomized db/db Mouse Model
15. P0990RENINAAV DOSE-DEPENDENTLY EXACERBATE ALBUMINURIA AND GLOMERULOSCLEROSIS, AND REDUCE GFR IN FEMALE UNINEPHRECTOMIZED DB/DB MICE
16. Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice
17. Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function
18. Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice
19. Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice
20. 2037-P: Characterization of Novel Unimolecular Amylin-Adrenomedullin Dual Agonists
21. 1103-P: Glucose-Responsive Insulin: An Unprecedented Cleavable Linker Concept
22. Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
23. Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin
24. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
25. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
26. Novel "Dual Hit" Rat Model of Diabetic Cardiomyopathy
27. Novel Rat Models of Diabetic Nephropathy Displaying Pronounced Tubular Fibrosis and Glomerular Alterations
28. Defective insulin secretion by chronic glucagon receptor activation in glucose intolerant mice
29. Peptides in metabolic diseases
30. Inhibition of Glycogen Phosphorylase and Glycogenolysis in Primary Rat Hepatocytes by 1,4-Dideoxy-1,4-Imino-D-Arabinitol
31. The Novel GLP-1–Gastrin Dual Agonist ZP3022 Improves Glucose Homeostasis and Increases β-Cell Mass without Affecting Islet Number in db/db Mice
32. Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
33. Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity
34. Use of glucagon-glucagon-like peptide 1 dual agonist as a positive inotropic agent for treatment of heart disease such as congestive heart failure, systolic dysfunction, myocardial infarction, and diabetic cardiomyopathy.
35. Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
36. Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin
37. Long-term characterization of the diet-induced obese and diet-resistant rat model:a polygenetic rat model mimicking the human obesity syndrome
38. Defective insulin secretion by chronic glucagon receptor activation in glucose intolerant mice.
39. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter
40. Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
41. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome
42. Kinetic and functional characterisation of 1,4-dideoxy-1,4-imino-D-arabinitol; a potent inhibitor of glycogen phosphorylase with antihyperglycaemic effect in ob/ob mice
43. Astrocyte Glycogen Sustains Neuronal Activity during Hypoglycemia: Studies with the Glycogen Phosphorylase Inhibitor CP-316,819 ([R-R*,S*]-5-Chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide)
44. Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle
45. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter
46. Evidence against Glycogen Cycling of Gluconeogenic Substrates in Various Liver Preparations
47. Kinetic and Functional Characterization of 1,4-Dideoxy-1,4-imino--arabinitol: A Potent Inhibitor of Glycogen Phosphorylase with Anti-hyperglyceamic Effect in ob/ob Mice
48. Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity.
49. Increased susceptibility to cardiovascular effectsof dihydrocapcaicin in resuscitated rats.Cardiovascular effects of dihydrocapsaicin.
50. Kinetic and Functional Characterization of 1,4-Dideoxy-1,4-imino-d-arabinitol: A Potent Inhibitor of Glycogen Phosphorylase with Anti-hyperglyceamic Effect in ob/ob Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.